Refine Results
  1. "Adult Leukemia"
Formats
  1. Journal Article (1360)
  2. Meeting Abstract (1277)
  3. Review (74)
  4. Book Section (38)
  5. Editorial (34)
  6. Research Letter (27)
  7. Conference Paper (14)
  8. Guidelines (14)
  9. Correspondence (6)
  10. Miscellaneous (2)
  11. Book Whole (1)
Groups
  1. Adult Leukemia (2847)
  2. Center for Hematologic Malignancies (2847)
  3. Department of Medicine (2817)
  4. Hematologic Malignancies, Division of (2813)
  5. GSK Faculty (1515)
  6. Hematologic Malignancies Research (811)

More Groups

People
  1. Ross Levine (633)
  2. Martin Tallman (596)
  3. David Scheinberg (469)
  4. Renier Brentjens (274)
  5. Omar Abdel-Wahab (240)
  6. Jae Park (235)

More People

Years
  1. 2022 (54)
  2. 2021 (177)
  3. 2020 (215)
  4. 2019 (275)
  5. 2018 (259)
  6. 2017 (204)

More Years

Publications
  1. Blood (844)
  2. Journal of Clinical Oncology (167)
  3. Haematologica (93)
  4. Leukemia (88)
  5. Cancer Research (82)
  6. Clinical Lymphoma, Myeloma and Leukemia (80)

More Publications

Publishers
  1. American Society of Hematology (899)
  2. Nature Publishing Group (260)
  3. Elsevier Inc. (204)
  4. American Association for Cancer Research (200)
  5. American Society of Clinical Oncology (177)
  6. Ferrata Storti Foundation (93)

More Publishers

Results (2847)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in previously treated mantle cell lymphoma: Updated results from the phase 1/2 BRUIN study
    Meeting Abstract

    Wang, M.; Shah, N.; Alencar, A.; Gerson, J.; Patel, M.; Fakhri, B.; Jurczak, W.; Tan, X.; Lewis, K.; Fenske, T.; more...
    British Journal of Haematology (2022)

    Fulltext@MSK | Save
  • Exploratory analysis: Potential of pelabresib (CPI-0610), a bromodomain and extra-terminal domain inhibitor, as suggested by analysis of improvements in bone marrow histology and function in patients with myelofibrosis-preliminary data
    Meeting Abstract

    Harrison, C.; Verstovsek, S.; Salama, M. E.; Mascarenhas, J.; Talpaz, M.; Mesa, R.; Vannucchi, A. M.; Rampal, R. K.; Oh, S.; Olteanu, H.; more...
    British Journal of Haematology (2022)

    Fulltext@MSK | Save
  • Pelabresib (CPI-0610) monotherapy in patients with myelofibrosis - Update of clinical and translational data from the ongoing MANIFEST trial
    Meeting Abstract

    Curto-Garcia, N.; Kremyanskaya, M.; Mascarenhas, J.; Palandri, F.; Vannucchi, A. M.; Verstovsek, S.; Harrison, C.; Bose, P.; Schiller, G. J.; Rampal, R.; more...
    British Journal of Haematology (2022)

    Fulltext@MSK | Save
  • Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in previously treated CLL/SLL: Updated results from the phase 1/2 BRUIN study
    Meeting Abstract

    Mato, A.; Pagel, J.; Coombs, C.; Shah, N.; Lamanna, N.; Munir, T.; Lech-Maranda, E.; Eyre, T.; Woyach, J.; Wierda, W.; more...
    British Journal of Haematology (2022)

    Fulltext@MSK | Save
  • Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukaemia: Final 5-year results from the BFORE trial
    Meeting Abstract

    Milojkovic, D.; Brümmendorf, T. H.; Cortes, J. E.; Gambacorti-Passerini, C.; Clark, R. E.; Le Coutre, P.; García-Gutierrez, V.; Chuah, C.; Kota, V.; Lipton, J. H.; more...
    British Journal of Haematology (2022)

    Fulltext@MSK | Save
  • Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
    Journal Article

    Smith, M.; Dai, A.; Ghilardi, G.; Amelsberg, K. V.; Devlin, S. M.; Pajarillo, R.; Slingerland, J. B.; Beghi, S.; Herrera, P. S.; Giardina, P.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Treatment outcomes with purine nucleoside analog alone or with rituximab for hairy cell leukemia at first relapse
    Journal Article

    Hu, R.; Wei, W.; Mian, A.; Gonter-Aubin, K.; Kabel, C.; Mato, A.; Stephens, D. M.; Hanlon, A.; Khajavian, S.; Shadman, M.; more...
    European Journal of Haematology (2022)

    Fulltext@MSK | Save
  • Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplant
    Journal Article

    Miltiadous, O.; Waters, N. R.; Andrlová, H.; Dai, A.; Nguyen, C. L.; Burgos da Silva, M.; Lindner, S.; Slingerland, J.; Giardina, P.; Clurman, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Treatment of patients with acute myeloid leukemia with the targeted alpha-particle nanogenerator (225)actinium-lintuzumab
    Journal Article

    Rosenblat, T. L.; McDevitt, M. R.; Carrasquillo, J. A.; Pandit-Taskar, N.; Frattini, M. G.; Maslak, P. G.; Park, J. H.; Douer, D.; Cicic, D.; Larson, S. M.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Ibrutinib-associated dermatologic toxicities: A systematic review and meta-analysis
    Review

    Nocco, S.; Andriano, T. M.; Bose, A.; Chilov, M.; Godwin, K.; Dranitsaris, G.; Wu, S.; Lacouture, M. E.; Roeker, L. E.; Mato, A. R.; more...
    Critical Reviews in Oncology/Hematology (2022)

    Fulltext@MSK | Save